Mesoblast (MESO) Cash & Equivalents (2015 - 2026)
Mesoblast (MESO) posted Cash & Equivalents of $102.91 million for the quarter ended Jun 30, 2026, down 36.3% from $161.55 million a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Cash & Equivalents (2015 - 2026) Analysis & Trends
Since the quarter ended Jun 30, 2015, Mesoblast has reported Cash & Equivalents for 39 quarters.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -5.5% (years ended Jun 2021 to Jun 2026).
- In prior years, Mesoblast's Cash & Equivalents was $161.55 million in the year ended Jun 30, 2025 (+156.6%), $62.96 million in the year ended Jun 30, 2024 (-11.7%), $71.32 million in the year ended Jun 30, 2023 (+18.0%) and $60.45 million in the year ended Jun 30, 2022 (-55.8%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Cash & Equivalents since the quarter ended Dec 31, 2024.
- On a year-over-year basis, Cash & Equivalents increased in two of the last four quarters, with growth averaging 77.8%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was the quarter ended Dec 31, 2025, with growth of 241.8%; the weakest was the quarter ended Jun 30, 2022, with a decline of 55.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Mesoblast | 1.85 Bn | 1.42 Bn | - | 102.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 102.91 Mn |
| Dec 31, 2025 | 129.98 Mn |
| Jun 30, 2025 | 161.55 Mn |
| Dec 31, 2024 | 38.03 Mn |
| Jun 30, 2024 | 62.96 Mn |
| Dec 31, 2023 | 77.55 Mn |
| Jun 30, 2023 | 71.32 Mn |
| Mar 31, 2023 | 48.80 Mn |
| Dec 31, 2022 | 67.62 Mn |
| Sep 30, 2022 | 85.50 Mn |
| Jun 30, 2022 | 60.45 Mn |
| Mar 31, 2022 | 76.76 Mn |
| Dec 31, 2021 | 94.85 Mn |
| Sep 30, 2021 | 115.96 Mn |
| Jun 30, 2021 | 136.88 Mn |
| Mar 31, 2021 | 158.26 Mn |
| Dec 31, 2020 | 77.53 Mn |
| Sep 30, 2020 | 108.12 Mn |
| Jun 30, 2020 | 129.33 Mn |
| Mar 31, 2020 | 60.08 Mn |
API Access
Mesoblast Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();